Haier Biomedical News
Haier Biomedical’s Success @Medica 2023!
In MEDICA, dealers from various countries engaged in in-depth discussions on cutting-edge technologies. Haier Biomedical took the opportunity to present its comprehensive solutions and future development plans, allowing the global audience to gain a deeper understanding of Haier Biomedical.
Haier Biomedical Awarded the Best Asia Pacific Layout Case for Medical Devices Going Abroad in 2023
Products + Services: Haier Biomedical Launches Vietnam’s First Constant Temperature and Humidity Chamber
Haier Biomedical Distributor Conference Concluded
Haier Biomedical 2023 AACR exhibition was a success
Haier Biomedical’s 2022 Corporate Social Responsibility Report Released
Haier Biomedical’s operating income in 2022 was $41.43million
Unlocking the Power of Ultra-Low Temperature Freezers: Why Validation is Crucial for Success!
Haier Biomedical Supports the Development of Japan
Known as the forever sunrise industry, the biomedicine industry is closely related to the length and quality of people’s life, and it is developing rapidly in various countrie
Haier Biomedical’s Acquisition of Suzhou Kangsheng Demonstrates its Ambition to Further Expand Smart Laboratory Solution Scenarios
Haier Biomedical: Pioneering Technological Precision in Pharmaceutical Innovation
Opening a New Era in Digital Blood Management by "EmpoweringPrecision Healthcare with Haier Biomedical
Responding to this demand, Haier Biomedical has equipped the hospital with three units of its HXC-629R blood refrigerator, empowering it to embark on a journey toward digital blood management. These intelligent blood refrigerators integrate seamlessly with the hospital’s existing network infrastructure, and interface directly with both the hospital information system (HIS) and Haier’s smart blood transfusion management system, facilitating a unified management approach to information across the healthcare facility. This enables the hospital to conduct real-time analysis of blood usage data, monitor blood inventory levels, and visualize the blood management processes.
Haier Biomedical Gives Impetus to Develop Blood Management Solutions in Tanzania
Haier Biomedical Drives Initiatives to Develop Public Health Solutions in Turkiye
Prioritizing the investment of medical infrastructure to ensure the health and well-being of its residents, the Türkiye Ministry of Health has recently issued a tender notice for a national public health project to procure products including Ultra-Low Temperature Freezers, CO2 Incubators, and Autoclaves. In a competitive bidding process, Haier Biomedical, an eco-brand of digital scenarios of life sciences and healthcare innovations, emerged as the successful bidder, securing the contract by virtue of the excellent quality of its products.
Haier Biomedical Smart Frequency Conversion ULT Freezers Deployed in Florida
Haier Biomedical, with its user-centric service concept and high-quality products, has recently secured the favor of BCW Florida, providing 12 sets of inverter ultra-low temperature freezers for the company’s experimental research. The feedback on the equipment’s usage has been positive, earning Haier Biomedical recognition and trust from BCW experts.
The Evolution of Liquid Nitrogen Containers
As medical technology advances, the in-depth exploration of -196℃ cryogenic technology holds promises and possibilities for human health. Focusing on user needs, Haier Biomedical remains dedicated to innovation, and has introduced a comprehensive one-stop liquid nitrogen container storage solution for all scenarios and volume segments, ensuring that the value of stored samples is maximized and continuously contributing to the field of life sciences.
A Guide to Fighting Mycoplasma Pneumonia
Haier Biomedical’s Autoclave stands out in this field with its multiple sterilization functions and advanced control system, as well as its one-click automation and convenient operation, comprehensively meeting the high-efficiency and safe sterilization requirements of various medical and healthcare facilities, as well as biomedical research centers.